Polypharmacy in the management of patients with schizophrenia on risperidone in a tertiary-care hospital in Malaysia

SA Jacob, MI Mohammed Ibrahim, F Mohammed

Research output: Contribution to journalArticle

Abstract

The present study was conducted primarily to determine the occurrence of polypharmacy in patients with schizophrenia on risperidone. The secondary aim was to ascertain the incidence of inappropriate prescribing with anticholinergics. A retrospective review of the medical records of all patients who were being followed up at the outpatient clinic of a tertiary-care hospital in Malaysia was conducted. Only patients who were being prescribed risperidone between 1 June 2008 and 31 December 2008 were included in the study. Demographic data such as patient’s age, gender and race were obtained from the patient’s medical records. In total, 113 patients met the selection criteria. Polypharmacy was found to occur in 34 patients (30.09%), with the majority (76.47%) being on two antipsychotics. In total, 27 patients (34.18%) on monotherapy with risperidone were prescribed an anticholinergic on scheduled dosing, while 19 patients (24.05%) were prescribed it on an as-needed basis. Of the patients on polypharmacy, 26 (76.47%) were on scheduled dosing of anticholinergics, while three (8.82%) were taking the medication on an as-needed basis. Polypharmacy should be avoided, and the use of anticholinergics should be closely reviewed. By adopting more efficient prescribing practices, costs can be reduced and financial resources can instead be channelled towards more beneficial areas for the patients.
Original languageEnglish
Pages (from-to)37-43
Number of pages7
JournalMental Health in Family Medicine
Volume10
Publication statusPublished - 31 Mar 2013

Fingerprint

Polypharmacy
Risperidone
Malaysia
Tertiary Healthcare
Tertiary Care Centers
Schizophrenia
Cholinergic Antagonists
Patient Selection
Medical Records
Inappropriate Prescribing
Ambulatory Care Facilities
Antipsychotic Agents
Demography
Costs and Cost Analysis

Keywords

  • anticholinergic
  • antipsychotic
  • polypharmacy
  • risperidone
  • schizophrenia

Cite this

@article{ee8c4260ec514a35a5ad8bf9b92be657,
title = "Polypharmacy in the management of patients with schizophrenia on risperidone in a tertiary-care hospital in Malaysia",
abstract = "The present study was conducted primarily to determine the occurrence of polypharmacy in patients with schizophrenia on risperidone. The secondary aim was to ascertain the incidence of inappropriate prescribing with anticholinergics. A retrospective review of the medical records of all patients who were being followed up at the outpatient clinic of a tertiary-care hospital in Malaysia was conducted. Only patients who were being prescribed risperidone between 1 June 2008 and 31 December 2008 were included in the study. Demographic data such as patient’s age, gender and race were obtained from the patient’s medical records. In total, 113 patients met the selection criteria. Polypharmacy was found to occur in 34 patients (30.09{\%}), with the majority (76.47{\%}) being on two antipsychotics. In total, 27 patients (34.18{\%}) on monotherapy with risperidone were prescribed an anticholinergic on scheduled dosing, while 19 patients (24.05{\%}) were prescribed it on an as-needed basis. Of the patients on polypharmacy, 26 (76.47{\%}) were on scheduled dosing of anticholinergics, while three (8.82{\%}) were taking the medication on an as-needed basis. Polypharmacy should be avoided, and the use of anticholinergics should be closely reviewed. By adopting more efficient prescribing practices, costs can be reduced and financial resources can instead be channelled towards more beneficial areas for the patients.",
keywords = "anticholinergic, antipsychotic, polypharmacy, risperidone, schizophrenia",
author = "SA Jacob and {Mohammed Ibrahim}, MI and F Mohammed",
year = "2013",
month = "3",
day = "31",
language = "English",
volume = "10",
pages = "37--43",
journal = "Mental Health in Family Medicine",
issn = "1756-8358",

}

Polypharmacy in the management of patients with schizophrenia on risperidone in a tertiary-care hospital in Malaysia. / Jacob, SA; Mohammed Ibrahim, MI; Mohammed, F.

In: Mental Health in Family Medicine, Vol. 10, 31.03.2013, p. 37-43.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Polypharmacy in the management of patients with schizophrenia on risperidone in a tertiary-care hospital in Malaysia

AU - Jacob, SA

AU - Mohammed Ibrahim, MI

AU - Mohammed, F

PY - 2013/3/31

Y1 - 2013/3/31

N2 - The present study was conducted primarily to determine the occurrence of polypharmacy in patients with schizophrenia on risperidone. The secondary aim was to ascertain the incidence of inappropriate prescribing with anticholinergics. A retrospective review of the medical records of all patients who were being followed up at the outpatient clinic of a tertiary-care hospital in Malaysia was conducted. Only patients who were being prescribed risperidone between 1 June 2008 and 31 December 2008 were included in the study. Demographic data such as patient’s age, gender and race were obtained from the patient’s medical records. In total, 113 patients met the selection criteria. Polypharmacy was found to occur in 34 patients (30.09%), with the majority (76.47%) being on two antipsychotics. In total, 27 patients (34.18%) on monotherapy with risperidone were prescribed an anticholinergic on scheduled dosing, while 19 patients (24.05%) were prescribed it on an as-needed basis. Of the patients on polypharmacy, 26 (76.47%) were on scheduled dosing of anticholinergics, while three (8.82%) were taking the medication on an as-needed basis. Polypharmacy should be avoided, and the use of anticholinergics should be closely reviewed. By adopting more efficient prescribing practices, costs can be reduced and financial resources can instead be channelled towards more beneficial areas for the patients.

AB - The present study was conducted primarily to determine the occurrence of polypharmacy in patients with schizophrenia on risperidone. The secondary aim was to ascertain the incidence of inappropriate prescribing with anticholinergics. A retrospective review of the medical records of all patients who were being followed up at the outpatient clinic of a tertiary-care hospital in Malaysia was conducted. Only patients who were being prescribed risperidone between 1 June 2008 and 31 December 2008 were included in the study. Demographic data such as patient’s age, gender and race were obtained from the patient’s medical records. In total, 113 patients met the selection criteria. Polypharmacy was found to occur in 34 patients (30.09%), with the majority (76.47%) being on two antipsychotics. In total, 27 patients (34.18%) on monotherapy with risperidone were prescribed an anticholinergic on scheduled dosing, while 19 patients (24.05%) were prescribed it on an as-needed basis. Of the patients on polypharmacy, 26 (76.47%) were on scheduled dosing of anticholinergics, while three (8.82%) were taking the medication on an as-needed basis. Polypharmacy should be avoided, and the use of anticholinergics should be closely reviewed. By adopting more efficient prescribing practices, costs can be reduced and financial resources can instead be channelled towards more beneficial areas for the patients.

KW - anticholinergic

KW - antipsychotic

KW - polypharmacy

KW - risperidone

KW - schizophrenia

UR - http://www.mhfmjournal.com/index.php

M3 - Article

VL - 10

SP - 37

EP - 43

JO - Mental Health in Family Medicine

JF - Mental Health in Family Medicine

SN - 1756-8358

ER -